Gabriela Cezar is a faculty member at the University of Wisconsin—Madison where she pioneered the application of metabolomics to stem cell biology. Her research involves human embryonic stem (hES) cells, cancer stem cells and cells derived from hES cells such as neurons, cardiomyocytes and hepatocyte-like cells. In addition, Dr. Cezar heads the Stem Cell Safety Sciences Lab at UW and is a scientific collaborator with WiCell Research Institute. Overall, her research program is focused on unraveling biochemical pathways of neurodevelopmental disorders and cancer. Prior to joining the faculty at UW-Madison in 2005, Dr. Cezar served as a senior principal scientist at Pfizer Inc., working on global projects to incorporate stem cells in drug discovery and toxicology. In her role at Pfizer, Dr. Cezar developed mouse embryonic stem cell-based models for drug discovery in multiple therapeutic areas and predictive toxicity, including a model for cardiotoxicity (QT prolongation with cardiomyocytes from mouse ES cells.

Dr. Cezar is a member of Standard & Poor’s Society of Industry Leaders and serves on the scientific advisory board of stem cell technology and patient advocacy organizations. She is an internationally renowned invited speaker at numerous conferences.